title: Visualization of IL-22-expressing Lymphocytes Using Reporter Mice.
abstract: Reporter mice have been widely used to observe the localization of expression of targeted genes. This protocol focuses on a strategy to establish a new transgenic reporter mouse model. We chose to visualize interleukin (IL) 22 gene expression because this cytokine has important activities in the intestine, where it contributes to repair tissues damaged by inflammation. Reporter systems offer considerable advantages over other methods of identifying products in vivo. In the case of IL-22, other studies had first isolated cells from tissues and then re-stimulated the cells in vitro. IL-22, which is normally secreted, was trapped inside cells using a drug, and intracellular staining was used to visualize it. This method identifies cells capable of producing IL-22, but it does not determine whether they were doing so in vivo. The reporter design includes inserting a gene for a fluorescent protein (tdTomato) into the IL-22 gene in such a way that the fluorescent protein cannot be secreted and therefore remains trapped inside the producing cells in vivo. Fluorescent producers can then be visualized in tissue sections or by ex vivo analysis through flow cytometry. The actual construction process for the reporter included recombineering a bacterial artificial chromosome that contained the IL-22 gene. This engineered chromosome was then introduced into the mouse genome. Homeostatic IL-22 reporter expression was observed in different mouse tissues, including the spleen, thymus, lymph nodes, Peyer's patch, and intestine, by flow cytometry analysis. Colitis was induced by T-cell (CD4+CD45RBhigh) transfer, and reporter expression was visualized. Positive T cells were first present in the mesenteric lymph nodes, and then they accumulated inside the lamina propria of the distal small intestine and colon tissues. The strategy using BACs gave good-fidelity reporter expression compared to IL-22 expression, and it is simpler than knock-in procedures.
authors.affiliation: Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health.
authors.forename: Wei
authors.initials: W
authors.lastname: Shen
authors.affiliation: Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health.
authors.forename: Wenqing
authors.initials: W
authors.lastname: Li
authors.affiliation: Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health.
authors.forename: Julie A
authors.initials: JA
authors.lastname: Hixon
authors.affiliation: Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health.
authors.forename: Caroline
authors.initials: C
authors.lastname: Andrews
authors.affiliation: Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health; durums@mail.nih.gov.
authors.forename: Scott K
authors.initials: SK
authors.lastname: Durum
mesh_terms: D000818:Animals; D022202:Chromosomes, Artificial, Bacterial; D003092:Colitis / Q000235:genetics / Q000473:pathology; D005434:Flow Cytometry / Q000379:methods; D017930:Genes, Reporter; D005818:Genetic Engineering / Q000379:methods*; D007378:Interleukins / Q000032:analysis* / Q000235:genetics / Q000378:metabolism; D008198:Lymph Nodes / Q000166:cytology; D008822:Mice, Transgenic; D010581:Peyer's Patches / Q000166:cytology; D013154:Spleen / Q000166:cytology; D013535:Suspensions; D013601:T-Lymphocytes / Q000166:cytology / Q000378:metabolism; D000097043:Interleukin-22
chemical_list: D007378:Interleukins; D013535:Suspensions; D000097043:Interleukin-22